hotspot -WSS

hotspot

author：knowledge 2025-09-29 18:15:44 - browse：46

This is the inaugural edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

Hello! Welcome to the premiere issue of Adam’s Biotech Scorecard. I’m excited to get started. Let’s do this! (By the way, the AF in the logo are my initials, not the “other” AF.)

The contrarian view of Viking Therapeutics

Closeup financial chart

The developer of a dual-acting GLP-1/GIP treatment for obesity is riding high on positive data and takeout speculation. The drug, called VK2735, has shown impressive weight loss with minimal gastrointestinal side effects in both subcutaneous and oral formulations, positioning it as a strong challenger to the obesity juggernauts from Eli Lilly and Novo Nordisk. With a stock price that has soared nearly 800% over the past year, Viking is now a $9 billion company and a prime acquisition target for a cash-rich pharma company.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Health officials lay out plans to cope with respiratory virus season

entertainment

WSS

Listen: Your guide to Wegovy's blockbuster heart study

How the first Native Hawaiian psychiatrist helped diversify medicine

Wegovy improves function in certain heart failure patients

Health officials lay out plans to cope with respiratory virus season

Who are the detained American citizens released from prison in Iran?

CDC says it’s too soon to assess risk posed by Covid subvariant

focus

hotspot

The contrarian view of Viking Therapeutics

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Wegovy improves function in certain heart failure patients

Bright Health sells Medicare Advantage business to Molina

White House drug shortages task force keeps mum with Congress

State Dept. review finds Biden bears some blame for Afghanistan failures

Large hospital system sues Multiplan for low

As demand for Covid shots wanes, Moderna seeks its next success

Genentech weighs delaying cancer therapy after drug pricing law

23andMe had bad news about my health. I wish a person had delivered it

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

hotspot

Can U.S. cancer drug shortages be fixed?

Some of the ways extreme heat will change life as we know it

Maui funeral service workers on devastation of fires: 'I'm in shock'

House GOP releases memo on Hunter Biden foreign business dealings, reviving old claims

NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

CDC overhauls leadership of center that led response to Covid

hotspot

entertainment

hotspot

entertainment